Pulse ·

Australia is mailing every 50-year-old a dementia prevention letter

By Dr HB Lo, FACRRM 4 min read
Verdict Yes — worth knowing about

The federal government is mailing dementia prevention letters to every Australian who turned 50 in the year to June 2026. The timing aligns with the WHO's July 2026 guideline overhaul — the first in seven years — which found up to 45% of dementia cases are potentially preventable. Key modifiable targets include hypertension, physical inactivity, smoking, social isolation, and unmanaged diabetes or elevated cholesterol.

For a 45-year-old woman, the letter is five years away — but modifiable risk factors respond best to early, sustained action. A GP review of blood pressure, fasting lipids, blood glucose, hearing, and mood is the practical starting point now.

What just happened

The Australian federal government is mailing dementia prevention letters to every person who turned 50 in the year to 30 June 2026, with the mailout running through July and August.

The letter opens: “Turning 50 is a good time to think about your future, and how you can stay healthier for longer.” It covers staying active, eating well, seeking help for mental health, and quitting smoking. GPs are being told to expect patients arriving with questions — and Australia’s Chief Medical Officer, Professor Michael Kidd, is encouraging practices to use the moment: “Every encounter with a patient is an opportunity to talk about prevention.”

The initiative arrives in the same month the World Health Organization published its first major overhaul of dementia prevention guidelines in seven years. Its headline number: up to 45% of dementia cases are potentially preventable through action on modifiable risk factors — a proportion that has shifted considerably upward from earlier estimates, as the evidence base for specific interventions has strengthened.

If you are 45, the government letter is five years away. That is the entire point of this post.

The both-and

What the guidelines actually say is modifiable

The WHO’s updated list of evidence-supported targets includes: hypertension, smoking, physical inactivity, diabetes, obesity, excessive alcohol, social isolation, depression, traumatic brain injury, air pollution, hearing loss, and elevated LDL cholesterol. Multidomain interventions addressing three or more risk factors simultaneously show the strongest benefit — meaning the most impactful thing is not picking the one “best” factor but addressing the cluster.

Several of these are directly addressed in general practice. Blood pressure management in midlife has some of the strongest evidence for dementia risk reduction of any modifiable factor. Hearing loss — frequently unaddressed in the forties because it feels gradual — carries independent evidence as a modifiable contributor. And social engagement is now understood not as a soft lifestyle factor but as a biologically active variable in brain health trajectories over decades.

One thing the guidelines did settle: widely-marketed supplement regimes don’t make the cut. Vitamins B and E, omega-3 polyunsaturated fatty acids, and standard multivitamin preparations are not recommended for reducing cognitive decline risk. The evidence does not support them for this purpose.

What a government letter cannot do

A one-page mailout is not a risk assessment. It plants a flag — your age group, your concern, starting now — but it cannot tell you which modifiable risk factors apply to you specifically, in what combination, or with what urgency.

The RACGP has called for structured care pathways and appropriate GP funding to translate population-level dementia prevention intention into meaningful clinical encounters. Right now, a long enough consultation — and a GP who uses the Red Book’s dementia prevention chapter as a framework — is what converts a government letter into a personalised risk conversation. Those consultations are not always easy to access or to fund.

The MHT question

Women approaching perimenopause will ask whether hormone therapy affects dementia risk. The WHO guidelines are precise here: MHT is not recommended for women 65 or older as a dementia risk reduction strategy. For women under 65, the evidence remains insufficient for a recommendation in either direction. This does not change the case for or against MHT in perimenopause symptom management — that conversation rests on different evidence and different goals. The two should not be conflated.

My two cents

Dementia is Australia’s leading cause of death. It is not a condition that begins at 80. The pathological changes — amyloid deposition, vascular change, neuroinflammation — accumulate across decades. The modifiable factors that matter most are most impactful when addressed in the decade or two before symptoms appear.

The 50-year-old letter is well-intentioned. But if you are 45, your modifiable risk window is now — not in five years when the letter arrives, and not at the first cognitive symptom.

The practical ask is not complicated: book a GP review that explicitly includes a dementia risk conversation. Bring your blood pressure history. Ask about fasting lipids and blood glucose if they have not been checked in the last two years. Mention any hearing changes, sleep problems, or persistent low mood — these are not separate conversations from brain health, they are the same conversation.

The 45% preventability figure is not a guarantee and it is not about any single habit. It is about the cluster. Starting the cluster conversation at 45 gives you the best available runway.

Verdict: yes — well-timed alignment between a national government initiative and the WHO’s strongest-evidence dementia prevention update in seven years. The 45% preventability figure is the one to hold.

Sources cited

  1. Dementia prevention letters sent to all 50-year-olds. RACGP NewsGP, 23 July 2026. https://www1.racgp.org.au/newsgp/professional/dementia-prevention-letters-sent-to-all-50-year-ol
  2. International overhaul of dementia guidelines unveiled. RACGP NewsGP, 20 July 2026. https://www1.racgp.org.au/newsgp/clinical/international-overhaul-of-dementia-guidelines-unve
  3. RACGP calls for clear pathways and support in dementia care. RACGP NewsGP. https://www1.racgp.org.au/newsgp/clinical/racgp-calls-for-clear-pathways-and-support-in-deme

Frequently asked questions

  • I'm 45 and haven't had blood pressure or cholesterol checked recently. Is that worth doing now specifically for dementia prevention?

    Yes. The WHO's updated guidelines give strong evidence support to managing hypertension and dyslipidaemia as dementia risk reduction strategies — independent of their cardiovascular benefits. If it has been more than two years since you had a fasting lipid panel, blood glucose measurement, and blood pressure check, those are the most evidence-supported starting points in your forties. Ask your GP to frame the review with dementia prevention as an explicit goal alongside the usual cardiovascular picture.

  • Does menopausal hormone therapy increase or reduce dementia risk?

    The WHO's updated dementia prevention guidelines are explicit: MHT is not recommended for women aged 65 or older specifically to reduce dementia risk. For women under 65, the evidence remains insufficient to support a recommendation in either direction — neither endorsing nor ruling it out for this purpose. MHT decisions for perimenopause symptom management are a separate matter and should be weighed on their own merits with your GP; this guideline update does not change that conversation.